Onto Innovation ONTO Street Sentiment and Analyst Perspectives AIM ImmunoTech Q1 2026 Earnings EPS Misses Estimates Significantly Stock Declines Traders Cast Doubt on Irans Strait of Hormuz Reopening Timeline